Fasika A. Woreta, M.D., M.P.H. is a cornea and cataract specialist and the Eugene de Juan, M.D. Professor of Ophthalmic Education at Wilmer Eye Institute’s Baltimore and Columbia locations. Her expertise is in in corneal and external eye diseases, including complex cataracts and anterior segment reconstruction following trauma. Dr. Woreta is currently the director of the Eye Trauma Center and the director of the Ophthalmology Residency Program at the Wilmer Eye Institute. An associate professor of ophthalmology, Dr. Woreta received her M.D. degree from the Johns Hopkins University School of Medicine and her M.P.H. degree from the Johns Hopkins Bloomberg School of Public Health. She completed her residency in ophthalmology at the Wilmer Eye Institute, then completed a fellowship in cornea and refractive surgery at the Bascom-Palmer Eye Institute at the University of Miami, as well as an accident and emergency and cataract fellowship at Moorfields Eye Hospital. Dr. Woreta is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. Her top areas of expertise are Endophthalmitis, Cataract, Hyphema, Cataract Removal, and Corneal Transplant.

T. Y. Alvin Liu, M.D. is the James P. Gills, Jr. M.D., and Heather Gills Rising Professor of AI and the founding director of the Wilmer Precision Ophthalmology Center of Excellence. He is originally from Hong Kong, and speaks fluent Cantonese and Mandarin. He attended Phillips Exeter Academy in Exeter, New Hampshire, and graduated from Cornell University with a dual major in biology and economics. He received his M.D. from Columbia University in 2012, and completed his residency (2016) and fellowship (surgical and medical retina- 2018) at Johns Hopkins. He is subspecialty-trained in the medical and surgical treatment of vitreoretinal diseases, including age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane and macular hole. Dr. Liu's research interests center on the application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, with a specific focus on vitreoretinal diseases such as age-related macular degeneration and diabetic retinopathy. In addition, he is involved in research on the pathogenesis of and treatment for pathologic myopia and the management of severe ocular trauma. Videos Dr. Tin Yan Alvin Liu Recent News Articles and Media Coverage AI Speeds Diabetic Retinopathy Diagnosis Without Specialist. Medscape August 28, 2018 AI Screening for Diabetic Retinopathy Moves to Retail Clinics. Medscape November 26, 2019 How Artificial Intelligence is Primed to Change Ophthalmology. Ophthalmology Advisor May 14, 2021 Medicine's first autonomous AI could prevent blindness due to diabetes. Stat News December 16, 2021 Innovations in Eye Care: How Technology is Transforming Ophthalmology. HealthTech November 29, 2022 Time to go multicultural. Retina Today March 1, 2023 How deep learning may play a role in predicting retinitis pigmentosa visual impairment. Ophthalmology Times March 14, 2023 AI in retinal diagnostics. Zhaoke Ophthalmology March 22, 2023 Macular Degeneration. Spotlight on Geographic Atrophy. Advances in Treatment. WebMD April 23, 2023 ARVO 2023: T.Y. Alvin Liu, MD discusses predictive AI and its application in ophthalmology. Modern Retina April 25, 2023 ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes. OptometryTimes May 5, 2023 Adopting and regulating AI in healthcare. BNN Bloomberg May 29, 2023 AI could increase health equity and boost adherence to annual eye examination in patients with diabetes. Modern Retina June 21, 2023 As more Marylanders grow older, a debilitating eye disease is gaining ground. The Baltimore Banner June 26, 2023. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Usher Syndrome Type 2A, Cone Rod Dystrophy Amelogenesis Imperfecta, Cone-Rod Dystrophy, and Stargardt Macular Degeneration.

Mariam Mathai is an Ophthalmologist in Columbia, Maryland. Dr. Mathai is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), and Vitrectomy. Dr. Mathai is currently accepting new patients.

Jonathan Etter is an Ophthalmologist in Columbia, Maryland. Dr. Etter is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Interstitial Keratitis, Cataract, Blepharitis, and Sjogren Syndrome. Dr. Etter is currently accepting new patients.

Lenard Hammer is an Ophthalmologist in Columbia, Maryland. Dr. Hammer is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Glaucoma, and Geographic Atrophy. Dr. Hammer is currently accepting new patients.

Olga Shif is an Ophthalmologist in Elkridge, Maryland. Dr. Shif is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy, and Vitrectomy. Dr. Shif is currently accepting new patients.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is rated as a Distinguished provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as a Distinguished provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Joseph Qureshi is an Ophthalmologist in Laurel, Maryland. Dr. Qureshi is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Interstitial Keratitis, Glaucoma, Ocular Hypertension (OHT), and Cataract. Dr. Qureshi is currently accepting new patients.

Kenneth Olumba is an Ophthalmologist in Baltimore, Maryland. Dr. Olumba is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Retinal Artery Occlusion, and Retinal Vein Occlusion. Dr. Olumba is currently accepting new patients.

John Gambrill is an Ophthalmologist in Catonsville, Maryland. Dr. Gambrill is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Coloboma of Optic Nerve, Coloboma of Optic Papilla, Allergic Conjunctivitis, and Ocular Hypertension (OHT). Dr. Gambrill is currently accepting new patients.

Peter L. Gehlbach, M.D., Ph.D. is the J. Willard Marriott, Jr. Professor of Ophthalmology with joint appointment in the Department of Electrical and Computer Engineering, The Whiting School of Engineering. A member of the Wilmer faculty since 2000, he was recruited by a national search to become the inaugural Maumenee Scholar at Johns Hopkins University School of Medicine. His clinical practice is composed of international, national, and regional patient populations with the most complex retinal disease. An expert vitreoretinal surgeon, Dr. Gehlbach has been a leader in performing and teaching complex surgical cases that require coordination with multiple ophthalmological specialists. His research interests include cutting-edge surgical approaches to patients with retinal disease and the development of novel surgical tools and approaches to retinal microsurgery. Dr. Gehlbach’s work has been supported by multiple NIH grants and prestigious foundations with research published in numerous peer-reviewed journals and presented at ophthalmology conferences around the world. The founding director of the former Wilmer Gene Therapy Vector Center, he has served as the director of the Wilmer Echography Center as well as the Retina Fellowship Training Program at Johns Hopkins. He holds multiple patents in both the U.S. and abroad. Dr. Gehlbach received his B.A. and M.D. degrees from the University of Vermont, and his Ph.D. in cell and integrative physiology from the University of Minnesota. He completed an internship and residency training in general surgery at the University of Health Sciences, Chicago Medical School. His ophthalmology residency was at Washington University in St. Louis, where he also completed a fellowship in protein chemistry. He completed a medical and surgical retina fellowship at the Casey Eye Institute in Portland. Dr. Gehlbach is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy.

Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Cindy X. Cai, M.D., is the Jonathan and Marcia Javitt Rising Professor of Ophthalmology and a retina specialist seeing patients at the Wilmer Eye Institute’s locations in the Baltimore, Maryland area. Her primary focuses are in medical and surgical retina treatments, including: diabetic retinopathy, diabetic macular edema, age-related macular degeneration, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane, and macular hole, among others. Dr. Cai graduated summa cum laude with a major in biology at Columbia University and received her M.D. from the Columbia University College of Physicians and Surgeons in New York. She completed her medical internship at Mercy Medical Center in Baltimore and her ophthalmology residency training at the Wilmer Eye Institute. She received her vitreoretinal surgery fellowship training at Duke Eye Center. Videos Dr. Cindy X. CaiOphthalmologist and Retina Specialist Recent News Articles and Media Coverage Continuing the Mission, Johns Hopkins Medicine (Dec. 2021) Get to Know Cindy Cai, Wilmer Insider (Apr. 2021). Dr. Cai is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. Her top areas of expertise are Diabetic Retinopathy, Diabetic Macular Edema (DME), Gyrate Atrophy of the Choroid and Retina, Vitrectomy, and Cataract Removal.

"Dr. Shah is an AUPO-fellowship trained ophthalmologist specializing in diseases of the retina, macula, and vitreous. A Pennsylvania native, Dr. Shah attended college at West Chester University of Pennsylvania. He later earned his medical degree at Drexel University College of Medicine and remained there to pursue his residency in Ophthalmology where he was also honored to serve as Chief Resident. Dr. Shah then pursued his fellowship training in vitreoretinal surgery at the Associated Retina Consultants in Phoenix, Arizona. Dr. Shah has been privileged to author or co-author over 40 book chapters and topics as well as publish scientific articles in peer-reviewed journals. He has been invited to lecture both physicians and students on current clinical issues. As a resident, he received multiple honors including Intern of the Year, Resident of the Year, and the Golden Apple for Teaching by the College of Medicine. He was even bestowed with Hahnemann University Hospital's highest award for training physicians – ""Excellence in Clinical Practice for a Fellow, Resident, or Intern."" Dr. Shah enjoys all aspects of retinal disease, but has particular interests in the management of acute, subacute, and chronic retinal disorders including age-related macular degeneration, diabetic retinopathy, and complex retinal detachments. Dr. Shah is a member of the American Society of Retinal Specialists and the American Academy of Ophthalmology.". Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Orbital Cellulitis, Hyphema, Kallikrein Hypertension, and Optic Nerve Atrophy.

Sadiq Syed is an Ophthalmologist in Glen Burnie, Maryland. Dr. Syed is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Eales Disease, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Hyphema. Dr. Syed is currently accepting new patients.

Marianne Cowley, M.D., is a clinical associate of ophthalmology and retina specialist at the Wilmer Eye Institute's Green Spring Station and Odenton, Maryland locations. Dr. Cowley specializes in the diagnosis and treatment of conditions such as age-related macular degeneration (dry and wet) and diabetic retinopathy. Dr. Cowley comes from private practice where she has focused on clinical excellence and patient experience in retinal care. For many years, Dr. Cowley volunteered her services with the University of Louisville and has made trips internationally to assist in providing retinal care. Dr. Cowley is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. Her top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Divya Srikumaran, M.D., is the Walter J. Stark Chair of Ophthalmology at the Wilmer Eye Institute, and practices at Wilmer's East Baltimore and Odenton, Maryland locations. She specializes in diagnosing and treating diseases of the cornea, performing corneal transplants, cataract surgeries, and refractive surgeries (LASIK). She is an investigator for several clinical trials at Wilmer offering her patients the latest treatment options. She has published numerous articles in peer-reviewed journals and lectures at national cornea and cataract conferences. Dr. Srikumaran, an associate professor of ophthalmology in the Division of Cornea and External Disease at the Johns Hopkins Wilmer Eye Institute received her M.D. degree from Northwestern University Feinberg School of Medicine, after which she completed her ophthalmology residency and cornea fellowship training at the Wilmer Eye Institute. Dr. Srikumaran’s research interest includes the assessment of corneal transplant outcomes and risk factors for receiving keratoplasty through big data sources including administrative claims data. She received the Hoskins Center IRIS Registry Research Fund Award through the American Academy of Ophthalmology as well as the EBAA Pilot Research grant to study real-world endothelial keratoplasty outcomes. She is a busy clinician who is actively involved in multi-central clinical trials in cornea. In addition, she serves on the scientific program committee of the EBAA and is participating in their Physician Leadership Program. She is also a member of the editorial board for Cornea and will serve as an associate editor for the society’s new journal Cornea Open. She is also a renowned educator and currently serves as Vice Chair of Education and was previously residency program director. As vice chair of education, she has an interest in medical education and studying best practices to support doctors in training and has been awarded several teaching awards. Blending her passion for both education and expertise in corneal surgery, Dr. Srikumaran has also studied barriers to adoption of advanced keratoplasty procedures in the US and abroad. Dr. Srikumaran is also an examiner and member of the cornea and cataract exam content development committees for the American Board of Ophthalmology and was selected to participate in their Visiting Scholar Program. Dr. Srikumaran is rated as an Experienced provider by MediFind in the treatment of Retinal Detachment. Her top areas of expertise are Cataract, Fuchs Dystrophy, Endophthalmitis, Corneal Transplant, and Cataract Removal.

Lisa Schocket is an Ophthalmologist in Baltimore, Maryland. Dr. Schocket is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration. Dr. Schocket is currently accepting new patients.

Joshua Fernandes is an Ophthalmologist in Silver Spring, Maryland. Dr. Fernandes is rated as an Advanced provider by MediFind in the treatment of Retinal Detachment. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Gyrate Atrophy of the Choroid and Retina.